42
New test on ARGIRELINE®
Lipotec has recently carried out a clinical study to test the anti-wrinkle efficacy of the well-known ARGIRELINE®
peptide at a
concentration of 2%. A test was performed on a panel of 24 female volunteers aged 35 to 45 years old. The volunteers taking part applied a cream twice a day, one containing the peptide on one half of the face and a placebo cream on the other. At the end of a 7 day treatment, there was a statistically significant decrease in average volume (- 20.6%) and length (- 15.9%) of wrinkles. ARGIRELINE®
peptide targets the pre-
synaptic pathway of the muscle contraction mechanism which relaxes the muscle instead of paralysing it. Clinical studies prove the efficacy of the topical approach in both preventing and attenuating expression wrinkles. The new results will allow for the development of novel cosmetic topical formulations claiming visible skin rejuvenation in just one week.
Lipotec, Stand 1K40
Safic-Alcan continuing the success story since acquiring Laserson
Since acquiring Laserson, Safic-Alcan has further enhanced its market position in the distribution of Cosmetic specialty ingredients. Safic-Alcan, an international distribution group of chemical specialties acquired Laserson, a French chemical distributor last September. Based in Etampes, France, Laserson brings to the table a history of
AQUALICIA®
supplying a large portfolio of ingredients via long-term collaborations. Safic-Alcan, a privately owned company founded in 1847 and based in Puteaux, France, also distributes specialties and active ingredients for the Performance Products and Life Sciences markets.
Safic-Alcan Deutschland GmbH, Stand 4E20 - Active Cellular Hydration
Laboratoires Expanscience is launching AQUALICIA®
at the show, a sustainable active
ingredient derived from the Acacia seed. Mainly harvested in Burkina Faso, Acacia
Macrostachya is a small African tree with biomimetic properties. Acacia Macrostachya grows in hot and arid climates and has adapted to survive these extreme environments. AQUALICIA®
offers a dual moisturising
action, revitalising the water flow and preserving the skins water content. It reinforces the skin barrier and optimises the water flow in the epidermis. A clinical study involving 27 volunteers showed that AQUALICIA®
increases:
• The NMF content by 104% • The water content by 129% • The thickness of the Stratum Corneum by 123%
Laboratoires Expanscience, Stand 3B30 Kuraray Europe GmbH, Stand 4J10
ISOPENTYLDIOL (IPD) is a water miscible, crystal- clear and odourless liquid, highly rated in terms of safety and versatility. Extremely compatible with other cosmetic ingredients and easy to formulate.
IPD offers the following key benefits: • A luxurious skin feel and incredible moisturising effect to skin and body care formulations
• A shiny effect in lipsticks and eye shadows • Helps to restore damaged hair when used in shampoos, conditioners or masks
• An effective replacement for propylene and hexylene glycols in make-up removers or cleansers
• Because of its amphiphilic properties, it is ideal for incorporating lipophilic actives in aqueous systems or water-soluble formulations
peptide shows wrinkle reduction in 1 week
Sun Care products that really shine
Take your sun protection products to new levels of performance with the latest innovations in film- forming technology from AkzoNobel Personal Care. DERMACRYL®
2.0 and DERMACRYL® E polymers
enable the development of sun protection products that feature high SPF, long-lasting water resistance and enhanced aesthetic properties. Cost-effective and easy-to-use, these new polymers provide the proven performance and a consumer perceptible benefit that today’s sun care products require. Whether you are formulating traditional emulsions, ethanol based spray products or even daily-wear moisturizers with SPF protection, new DERMACRYL®
2.0 and DERMACRYL® E polymers
will help you to secure your place in the sun. AkzoNobel Global Personal Care, Stand 1J30
IPD for versatility
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68